The potential for hormonal prevention trials
- 1 November 1994
- Vol. 74 (S9) , 2726-2733
- https://doi.org/10.1002/1097-0142(19941101)74:9+<2726::aid-cncr2820741823>3.0.co;2-s
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Breast cancer screening with mammography: overview of Swedish randomised trialsThe Lancet, 1993
- Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined AnnuallyJNCI Journal of the National Cancer Institute, 1989
- Chemoprevention of breast cancerBreast Cancer Research and Treatment, 1989
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial.BMJ, 1988
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implicationsThe Prostate, 1986
- BENEFICIAL EFFECT OF ADJUVANT TAMOXIFEN THERAPY IN PRIMARY BREAST CANCER PATIENTS WITH HIGH OESTROGEN RECEPTOR VALUESThe Lancet, 1985
- Diet and serum sex hormones in healthy menJournal of Steroid Biochemistry, 1984
- Treatment of Primary Breast Cancer with Chemotherapy and TamoxifenNew England Journal of Medicine, 1981
- A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474British Journal of Cancer, 1971